Human pluripotent stem-cells (HPSCs)—including human embryonic stem-cells and human induced pluripotent stem-cells—are reshaping the landscape of regenerative medicine.1,2 In Parkinson's disease, ...

With their unique ability to self-renew and differentiate into specific cell types, stem cells have already left an indelible mark on medicine, but researchers have only scratched the surface of their ...

Harvard Medical School will accredit a new Continuing Education course on stem cell therapies developed by the International Society for Stem Cell Research, launching in spring 2025. The course — ...

Stem cell bioprocessing represents a critical frontier in regenerative medicine, aiming to generate high-quality cells at scales appropriate for therapeutic use, disease modelling, and drug discovery.

A new study describes a technique that rejuvenates aging blood-forming stem cells and could help reduce the risk of age-related blood disorders.

PUERTO VALLARTA, Mexico — In the world of regenerative medicine, a new type of stem cell is generating excitement among scientists, physicians, and patients alike: MUSE cells, short for Multilineage ...

Scientists in Zurich have shown that stem cell transplants can reverse stroke damage by regenerating neurons, restoring motor functions, and even repairing blood vessels. The breakthrough not only ...

Embryonic stem cells (ESCs) are found in the inner cell mass of the human blastocyst, an early stage of the developing embryo lasting from the 4 th to 7 th day after fertilization. In normal embryonic ...